Frontage Holding (方达控股) IPO: Updates from 2018 Numbers
Frontage Holding, a contract research organization subsidiary of A-share listed Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...
780 Views
Discover SZ/SH Connect: Foreigners Were Buying Industries and Financials in December
In our Discover SZ/SH Connect series, we aim to help our investors understand the flow of northbound trades via the Shanghai Connect and Shenzhen...
563 Views
WuXi AppTec IPO Valuation: Bull/Bear Case DCF Scenarios
WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
534 Views
Ascentage Pharma (亚盛医药) IPO: Too Early for an IPO
Ascentage Pharma, a China-based biotech company, filed an application to list on the Hong Kong Stock Exchange. In this insight, we will cover the...
1.1k Views
WuXi Apptec (药明康德) IPO:Upside at Middle and Low End
Wuxi Apptec launched book building today with a price range of HKD 64.10 to HKD 71.50, planning to raise USD 954 million to USD 1,064 million. In...
751 Views